heparin/inflammation

Le lien est enregistré dans le presse-papiers

Choisissez le type de tri

Page 1 de 223 résultats

CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

After randomization, patients will be allocated to one of two groups: Control group (n = 45): patients on continuous hemodialysis (blood flow 150 ml / min, dose of 30 ml / kg / h) receiving anticoagulation with sodium citrate at 4 mmol / l. The dialysis system pressures, dialyzer patency and

Suloexide in the Treatment of Early Stages of COVID-19

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Objective: To use sulodexide in patients that have early onset of COVID-19 symptoms to mitigate the progression of the disease process that can allow them to recover at home, and limit the need for hospital care and the more severe manifestation which includes fulminant respiratory failure, acute

Obesity Surgery During 2020 Italian Pandemic

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Background Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) . The disease was first identified in December 2019 in Wuhan, the capital of China's Hubei province, and has since spread globally, resulting in the ongoing

Rehabilitation Needs and Functional Recovery in Covid-19 Acute and Post-acute Care

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

The disease caused by SARS-CoV-2 infection, COronaVIrus Disease-19 (COVID-19), was first reported on December 31, 2019. About 20% patients, mostly elderly people, suffered from a severe form of acute respiratory failure. COVID-19 is a new clinical entity, therefore its understanding is largely

Hesperidin and Diosmin for Treatment of COVID-19

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Research Background and Rationale At the end of December 2019, pneumonia of unknown origin was detected in the hospitals of Wuhan city, China, and reported to the WHO country office for the first time [1-3]. After a few days, the Chinese government has confirmed the human-to-human transmission of

Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

COVID 19 pandemic is a serious challenge for International medical community. There is lack of knowledge about the nature and character of the lung injury caused by this kind of infection. At the beginning COVID-associated lung injury was considered as typical ARDS, hence respiratory and

PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

INTRODUCTION 1.1 BACKGROUND Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is a new rapidly spreading infectious disease with no proven treatment options. The virus causes a spectrum of disease ranging from mild coryzal symptoms to severe respiratory compromise requiring

IVERMECTIN Aspirin Dexametasone and Enoxaparin as Treatment of Covid 19

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Between 30 and 50% of patients who contract COVID 19 will be asymptomatic or oligosymptomatic. This fact will not give rise to the consult, and will directly affect a notorious sub-registration of the cases. The second, even more disturbing, premise is that these patients are as contagious as the

Prasugrel in Severe COVID-19 Pneumonia

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Severe respiratory failure and multi-organ damage in coronavirus disease 2019 (COVID-19) patients have not a unitary pathophysiological interpretation. There is evidence of an association between the clinical entity of the disease and its severity with the plasma levels of D-dimer and inflammatory

Pulmonary Optical Coherence Tomography in COVID-19 Patients

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Background:Severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) infection represents a pandemic emergency of dramatic proportions. The clinical course of SARS-CoV-2 infection often meets the criteria for acute respiratory distress syndrome (ARDS), with progressive severity ultimately

Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

There are clinical data to support the observation that hospitalized acutely ill medical patients with severe viral pneumonitis/Acute Respiratory Distress Syndrome (ARDS), such as those with influenza H1N1 infection, have an over 23-fold increased risk for venous thromboembolism (VTE) - especially

Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

COVID-19 is a novel coronavirus that can cause severe and potentially fatal respiratory infections. COVID-19 has many similarities to previously seen coronaviruses, such as those that caused the Middle Eastern Respiratory Syndrome (MERS) that emerged in 2011 and the Severe Acute Respiratory Syndrome

Baricitinib Compared to Standard Therapy in Patients With COVID-19

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

There is urgent need of an effective therapy for Covid-19. To date, the best treatment of SARS-CoV-2 infection is unknown. Multiple strategies have been proposed and several randomized clinical trials are ongoing. Recently, data extracted from scientific literature by machine learning suggested a

Impact of an Intensified Thromboprofylaxis Protocol in COVID-19

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

Background Patients admitted to the Intensive Care Unit (ICU) are known to be at risk for thrombo-embolic events. Virchow's triad describes the major risk factors in three categories: venous stasis, vessel injury and activation of blood coagulation. A prolonged mechanical ventilation together with

Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC )

Seuls les utilisateurs enregistrés peuvent traduire des articles

Se connecter S'inscrire

This is a prospective, open-label, multicentre, Bayesian adaptive randomized clinical trial to establish whether therapeutic-dose parenteral anticoagulation improves outcomes for patients hospitalized with COVID-19 (e.g., reduces intubation or mortality). Participants will be randomized either to

Rejoignez notre
page facebook

Herbal & Natural Medicine

La base de données d'herbes médicinales la plus complète soutenue par la science

Fonctionne en 55 langues
Cures à base de plantes soutenues par la science
Reconnaissance des herbes par image
Carte GPS interactive - étiquetez les herbes sur place (à venir)
Lisez les publications scientifiques liées à votre recherche
Rechercher les herbes médicinales par leurs effets
Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets

Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées